OSIMERTINIB
osimertinib 40 mg tablet, 30
OSIMERTINIB (14162J)
14162J
Manner of administration:Oral
Restriction
Indication: Stage IB, II or IIIA non-small cell lung cancer
Treatment phase: Adjuvant therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $7,582.43 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tagrisso | |||||